MedTrace Logo

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane（IMPLANE-0529）

NCT05453721 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2026-05-07

No results posted yet for this study

Summary

This study is a multi-center, prospective, randomized controlled clinical trial. The purpose is to compare the difference of indocyanine green fluorescence imaging method and modified inflation-deflation method in identifying intersegmental plane in segmentectomy, and provide high-level evidence for the selection of intersegmental plane identification method in early NSCLC segmental resection.

Conditions

  • Segmentectomy
  • Non-small Cell Lung Cancer Stage I

Interventions

PROCEDURE

Indocyanine green fluorescence imaging method

Using indocyanine green fluorescence imaging method to identify intersegmental plane in segmentectomy

PROCEDURE

Modified inflation-deflation method

Using modified inflation-deflation method to identify intersegmental plane in segmentectomy

Sponsors & Collaborators

  • Dazhou Central Hospital

    collaborator OTHER

  • Ningde Municipal Hospital of Ningde Normal University

    collaborator UNKNOWN

  • First Affiliated Hospital of Gannan Medical University

    collaborator OTHER

  • Fuzhou Pulmonary Hospital of Fujian

    collaborator OTHER

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER

  • Ningbo No.2 Hospital

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    collaborator OTHER

  • Zhejiang Provincial People's Hospital

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • The First Affiliated Hospital of Nanchang University

    lead OTHER

Principal Investigators

  • Jian Tang, M.D., Ph.D · The First Affiliated Hospital of Nanchang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-04
Primary Completion
2024-11-19
Completion
2025-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05453721 on ClinicalTrials.gov